Genmab Announces US Court Judgment in Favor of Arzerra in Patent Infringement Lawsuit - Yahoo! Finance

Genmab A/S (Copenhagen:GEN.CO - News) announced today that a US District Court entered final judgment in favour of GlaxoSmithKline (GSK) in a patent infringement case involving Arzerra brought against GSK by Genentech and Biogen Idec.